2m 2m 2m 2m 2m 2m 2m
INHIBIKASE THRP (IKT)
NASDAQ
$1.63-$0.005 (-0.31%)
Price as of Oct 22, 2026 7:30 PM EDT- $227.4MMarket Cap
- 6.54%1-Year Change
- BiotechnologyIndustry
INHIBIKASE THRP (IKT)
$1.63-$0.005 (-0.31%)
IKT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.63 | ||
Change | -$0.03 (-1.81%) | ||
Open | $1.65 | ||
High | $1.65 | ||
Low | $1.58 | ||
Previous Close | $1.66 | ||
Volume | 310,490 | ||
30-Day Average Volume | 613,524 | ||
1-Week Change | -10.93% | ||
1-Month Change | -29.44% | ||
1-Year Change | 6.54% | ||
3-Year Change | 77.19% | ||
5-Year Change | -85.39% | ||
Fundamentals | |||
Shares Outstanding | 139.5M | ||
Total Assets | $163.6M | ||
Market Cap | $227.4M | ||
Enterprise Value | $196.2M | ||
Period: QTR TTM FY | |||
Revenue | $1.5M | ||
Net Income | -$19.6M | ||
Free Cash Flow | -$12.4M | ||
EBIT | -$19.6M | ||
EBITDA | -$19.6M | ||
Net Working Capital | $152.1M | ||
EPS | -$0.11 | ||
Enterprise Value/EBITDA | -10 | ||
Enterprise Value/Revenue | 134 | ||
P/B | 1 | ||
P/E | -15 | ||
PEG | 1 | ||
Price/Free Cash Flow | -18 | ||
Price/Operating Cash Flow | -18 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 6 | ||
Last Split Date | 06/30/2023 | ||
Earnings & Revenue